| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 12, 2004
Accepted on August 26, 2004
Department of Biology (S.D'A., S.I., F.A., M.M.,), University of Rome "Roma Tre", 00146 Roma, Italy; INSIBIO (Conicet-UNT) (R.N.F.) Chacabuco 461 (4000) San Miguel De Tucuman, Tucuman, Argentina; and Veterans Affairs Healthcare Network Upstate New York and Ordway Research Institute (F.B. Davis, P.J. Davis), Albany, New York 12208, USA
* To whom correspondence should be addressed. E-mail: incerpi{at}uniroma3.it.
3,5,3'-Triiodo-L-thyronine (L-T3) and L-Thyroxine (L-T4) activated the Na+/H+ exchanger of L-6 myoblasts, with a fast nongenomic mechanism, both in the steady-state and when cells undergo acid loading with ammonium chloride. Monitored with the intracellular pH-sensitive fluorescent probe 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein, activation of the exchanger appeared to be initiated at the plasma membrane, since T3-agarose reproduced the effect of L-T3, and triiodothyroacetic acid, a hormone analog previously shown to inhibit membrane actions of thyroid hormone, blocked the action of L-T3 on the exchanger. We show here for the first time that transduction of the hormone signal in this nongenomic response requires tyrosine kinase-dependent phospholipase C activation and two different signaling pathways: 1) mobilization of intracellular calcium, assessed by the fluorescent probe Fura-2, through activation of IP3-receptors and without contributions from extracellular calcium or ryanodine receptors; 2) protein phosphorylation involving protein kinase C and mitogen-activated protein kinase (MAPK; ERK1/2), as shown by the use of kinase inhibitors and by immunoblotting for activated kinases.
This article has been cited by other articles:
![]() |
S. Scapin, S. Leoni, S. Spagnuolo, A. M. Fiore, and S. Incerpi Short-term effects of thyroid hormones on Na+-K+-ATPase activity of chick embryo hepatocytes during development: focus on signal transduction Am J Physiol Cell Physiol, January 1, 2009; 296(1): C4 - C12. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamauchi, F. Kambe, X. Cao, X. Lu, Y. Kozaki, Y. Oiso, and H. Seo Thyroid Hormone Activates Adenosine 5'-Monophosphate-Activated Protein Kinase via Intracellular Calcium Mobilization and Activation of Calcium/Calmodulin-Dependent Protein Kinase Kinase-{beta} Mol. Endocrinol., April 1, 2008; 22(4): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mascanfroni, M. d. M. Montesinos, S. Susperreguy, L. Cervi, J. M. Ilarregui, V. D. Ramseyer, A. M. Masini-Repiso, H. M. Targovnik, G. A. Rabinovich, and C. G. Pellizas Control of dendritic cell maturation and function by triiodothyronine FASEB J, April 1, 2008; 22(4): 1032 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Irrcher, D. R. Walkinshaw, T. E. Sheehan, and D. A. Hood Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo J Appl Physiol, January 1, 2008; 104(1): 178 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Michienzi, B. Bucci, C. Verga Falzacappa, V. Patriarca, A. Stigliano, L. Panacchia, E. Brunetti, V. Toscano, and S. Misiti 3,3',5-Triiodo-L-thyronine inhibits ductal pancreatic adenocarcinoma proliferation improving the cytotoxic effect of chemotherapy J. Endocrinol., May 1, 2007; 193(2): 209 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet Overview of Nomenclature of Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 685 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Goulart da Silva, G. Giannocco, M. F. Santos, and M. T. Nunes Thyroid Hormone Induction of Actin Polymerization in Somatotrophs of Hypothyroid Rats: Potential Repercussions in Growth Hormone Synthesis and Secretion Endocrinology, December 1, 2006; 147(12): 5777 - 5785. [Abstract] [Full Text] [PDF] |
||||
![]() |
O A Sukocheva and D O Carpenter Anti-apoptotic effects of 3,5,3'-tri-iodothyronine in mouse hepatocytes. J. Endocrinol., November 1, 2006; 191(2): 447 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Hyyti, X.-H. Ning, N. E. Buroker, M. Ge, and M. A. Portman Thyroid hormone controls myocardial substrate metabolism through nuclear receptor-mediated and rapid posttranscriptional mechanisms Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E372 - E379. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Moeller, A. M. Dumitrescu, and S. Refetoff Cytosolic Action of Thyroid Hormone Leads to Induction of Hypoxia-Inducible Factor-1{alpha} and Glycolytic Genes Mol. Endocrinol., December 1, 2005; 19(12): 2955 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Incerpi Thyroid Hormones: Rapid Reply by Surface Delivery Only Endocrinology, July 1, 2005; 146(7): 2861 - 2863. [Full Text] [PDF] |
||||
![]() |
J. J. Bergh, H.-Y. Lin, L. Lansing, S. N. Mohamed, F. B. Davis, S. Mousa, and P. J. Davis Integrin {alpha}V{beta}3 Contains a Cell Surface Receptor Site for Thyroid Hormone that Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis Endocrinology, July 1, 2005; 146(7): 2864 - 2871. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |